|
|
||||||||
Institute of Internal Medicine, Cardiology and Heart Surgery
Department of Nuclear Medicine and Nuclear Medicine Center of the National Research Council, Institute of Radiological Sciences, University of Naples, Naples, Italy
Correspondence: For correspondence or reprints contact: Domenico Bonaduce, MD, Via Aniello Falcone, 394, 80127 Napoli, Italy.
ABSTRACT
This study evaluated the incremental prognostic value of 201Tl reinjection imaging over clinical, exercise and thallium stress-redistribution data in patients with previous myocardial infarction and left ventricular dysfunction. Methods: Thallium-201 reinjection after stress-redistribution SPECT was performed in 104 consecutive patients with a first Q-wave myocardial infarction (>8 wk)and left ventricular ejection fraction
40%. Follow-up data (mean 22 mo) were available for 98 patients; 16 patients underwent early revascularization procedures within 3 mo after exercise testing and were not considered for the analysis. Results During follow-up there were 13 hard events (cardiac death and myocardial infarction) and 11 soft events (coronary revascularization procedures >3 mo after thallium imaging). With multivariate Cox regression analysis, the sum of defects at stress-redistribution imaging that were reversible or moderate irreversible after reinjection was a powerful predictor of subsequent events. The addition of thallium reinjection imaging data significantly improved the prognostic power of clinical, exercise and stress-redistribution data for the occurrence of hard events (p < 0.01). Conclusion: In patient switch previous myocardial infarction and left ventricular dysfunction, thallium reinjection imaging provides incremental prognostic information over those obtained from conventional stress-redistribution imaging.
Key Words: myocardial infarction left ventricular dysfunction viable myocardium thallium reinjection imaging
This article has been cited by other articles:
![]() |
K. C. Allman, L. J. Shaw, R. Hachamovitch, and J. E. Udelson Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1151 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1159 - 1162. [Full Text] [PDF] |
||||
![]() |
R. Sciagra, M. Pellegri, A. Pupi, L. Bolognese, G. Bisi, V. Carnovale, and G. M. Santoro Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction J. Am. Coll. Cardiol., September 1, 2000; 36(3): 739 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pasquet, A. Robert, A.-M. D'Hondt, R. Dion, J. A. Melin, and J.-L. J. Vanoverschelde Prognostic Value of Myocardial Ischemia and Viability in Patients With Chronic Left Ventricular Ischemic Dysfunction Circulation, July 13, 1999; 100(2): 141 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Udelson Steps Forward in the Assessment of Myocardial Viability in Left Ventricular Dysfunction Circulation, March 10, 1998; 97(9): 833 - 838. [Full Text] [PDF] |
||||
![]() |
G. Srinivasan, A. N. Kitsiou, S. L. Bacharach, M. L. Bartlett, C. Miller-Davis, and V. Dilsizian [18F]Fluorodeoxyglucose Single Photon Emission Computed Tomography : Can It Replace PET and Thallium SPECT for the Assessment of Myocardial Viability? Circulation, March 10, 1998; 97(9): 843 - 850. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |